A study published in The New England Journal of Medicine has reported that the oral peptide icotrokinra, a selective ...
Following the first Phase 3 study of HyBryte(TM) for the treatment of CTCL, the FDA and the EMA indicated that they would require a second successful Phase 3 trial to support mark ...
FibroBiologics, Inc. ( ($FBLG) ) has shared an update. On November 18, 2025, FibroBiologics, Inc. entered into a securities purchase agreement ...
FLASH2 study Blinded Response Rate to Date Exceeds Trial Estimate PRINCETON, N.J., Nov. 19, 2025 /PRNewswire/ -- ...
Mustard oil, a centuries-old culinary staple, offers potential health benefits despite being banned for cooking in some ...
Bengaluru: Biocon has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received approval ...
Acne is the commonest skin disorder to affect adolescents and usually clears up once the hormone changes that bring on puberty calm down. However it is quite common for it to affect the face as well ...
In addition, in a concurrent private placement, the Company issued and sold unregistered warrants to purchase one share of its common stock for each share of common stock or pre-funded warrant ...
If the state of your skin is making you so miserable that you don¿t want to go out, then I think you should see your doctor. In the meantime, try applying good moisturising cream, such as E45, or ...
Dermatologists recommend avoiding hot showers in winter to prevent skin cracking and irritation; opt for lukewarm water instead.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback